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ObituaryBaruj Benacerraf (1921–2011)Baruj Benacerraf on the day he was notified that he had been awarded the Nobel Prize
in 1980. Photograph by Joe Wrinn, with permission from Harvard Medical School.With the recent passing of Baruj Benacer-
raf at the age of 90, the immunology
community has lost one of its pioneering
leaders. He was a corecipient of the
Nobel Prize in Medicine in 1980 for his
demonstration of the genetic control of
immune responses. Baruj also made
important contributions to our under-
standing of numerous other immunologic
phenomena. In addition, he was a
supremely gifted scientific administrator
and a devoted mentor for generations of
immunologists.
Perhaps his most important scientific
contribution was his description in the
early 1960s of the genetic control of
immune responses to administered for-
eign antigens. Observing that some
guinea pigs responded to an antigenic
challenge whereas others did not, he
showed through inbreeding experiments
that this responder versus nonresponder
status was genetically determined. He
postulated that the responder versus
nonresponder status was under the
control of what he called immune
response or Ir genes—what we now
know are genes encoding themajor histo-
compatibilty complex (MHC). The impor-
tance of these observations was recog-
nized in 1980 with a Nobel Prize, which
he shared with George Snell and Jean
Dausset.
Baruj’s background was a colorful one.
A member of a Sephardic Jewish family
involved in the international textile trade
(his father was Moroccan and his mother
Algerian), he was born in Venezuela and
raised in France. He received his under-
graduate degree at Columbia University
in New York City and medical degree
from the Medical College of Virginia in
Richmond. After a brief period of U.S.
military service as a physician in Germany
and France immediately following World
War II, Baruj did a fellowship in immu-
nology at Columbia University with Elvin
Kabat and then moved to France, where
he began his career in immunology while
overseeing his ailing father’s business
holdings.
In 1956, Baruj returned to the U.S. to
accept a faculty position at New York
University. He became Chief of Immu-
nology at the National Institute of Allergyand Infectious Disease in 1968 and then
moved to Harvard Medical School in
1970, where he became Chairman of
the Department of Pathology. In 1980,
he became President of the Harvard
Medical School-affiliated Dana-Farber
Cancer Institute.
As his career evolved, Baruj’s efficiency
and administrative prowess became
legendary. He launched his career as
an independent investigator while over-
seeing a substantial family business en-
terprise. At the height of his active pro-
fessional life, he simultaneously led the
Department of Pathology at Harvard
Medical School, the Dana-Farber Cancer
Institute during an unprecedented period
of growth in its clinical and research oper-
ations, and his own very active and
productive basic immunology laboratory.
One of Baruj’s life-long friends and
professional colleagues, Sheldon Wolff,
urged me to spend time working with
Baruj after I finished my clinical training
in medicine, saying that even if I eventu-
ally chose to pursue a career outside of
science, I would learn invaluable lessons
from Baruj on how to be a successful
administrator.Immunity 35While Baruj’s many achievements were
impressive, he claimed that his greatest
satisfaction came from mentoring young
immunologists. He cared deeply about
the professional success and personal
happiness of his fellows. In spite of his
many pressing administrative obligations,
he always found time to walk through the
laboratory every day and speak individu-
ally with each of his fellows about the
progress of his or her experiments. He
often called me at home in the evening
to discuss the outcome of an experiment
if the results were not apparent by the
end of the usual work day. Perhaps most
importantly, his mentoring did not end
when a fellow left the laboratory to
embark on an independent career. As he
did with many others who trained with
him, Baruj continued to provide me with
invaluable advice on scientific and profes-
sional issues as my career progressed. It
is not surprising that Baruj’s fellows have
gone on to make major contributions to
our understanding of the immune system
and have played major leadership roles
in the field of immunology.
Central to his success as a mentor was
his genuine feeling that each of his fellows, August 26, 2011 ª2011 Elsevier Inc. 147
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Obituarywas a member of his family. During his
time at Harvard Medical School, he often
had members of his laboratory join him,
his wife Annette, and his daughter Beryl
for dinners at their apartment or week-
ends at their summer home on Cape
Cod. This sense of family carried over to148 Immunity 35, August 26, 2011 ª2011 Elshismany fellowswho grew to feel an inter-
generational bond as members of Baruj’s
extended family. It is, therefore, only
natural that Baruj’s passing leaves all of
us in the community of immunologists
with a deep feeling of personal loss, the
loss of a member of our family.evier Inc.Norman L. Letvin1,*
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